Osteomyelitis Clinical Trial
Official title:
Diagnostic Tests to Help Determine Osteomyelitis: an Analysis and Comparison of Clinical Signs, Microbiology, Pathology and Radiology.
In this study, the investigators will perform a retrospective chart analysis of patients that underwent a bony debridement or amputation in the operating room at Georgetown University Hospital during 2009-2010 under Drs. Steinberg and Attinger. Chart reviews, medical records and operative reports via EMR and paper charts will be examined from inpatient records, the Center for Wound Healing, the Emergency Department as well as other institutions involved in the care of the subjects to gather data.
Osteomyelitis is present in approximately 20% of cases of foot infection in persons with
diabetes [1, 2] and greatly increases the likelihood that the patient will require a
lower-extremity amputation [3, 4]. Early diagnosis and treatment drastically improves
prognosis. While there are multiple modalities through which osteomyelitis is diagnosed,
unfortunately there is no definitive method. Bone biopsy with histopathological and
microbiological analysis has been deemed the gold standard for diagnosing osteomyelitis [3,
5].
Osteomyelitis is considered proven if one or more pathogens are cultured from a reliably
obtained bone specimen that shows bone death, acute or chronic inflammation and reparative
responses on histological examination. However, histological analysis can also produce
falsely positive results based on sampling error or if there are other causes of
inflammation [6]. Furthermore, a recent study done by Meyr et al. has highlighted a
discrepancy amongst pathologists that leaves the medical community questioning the validity
of some pathological diagnoses.
Microbiological analysis can differ based on specimen processing and is also dependent on
sampling technique. Often results can be falsely negative because of sampling error, prior
antibiotic therapy, or inability to culture fastidious organisms; likewise, they may be
falsely positive because of contamination by wound-colonizing flora [6].
Also, cultures of superficial swab samples from diabetic ulcers and sinus tracts may not
adequately identify the true bacteriological characteristics of diabetic foot osteomyelitis
because of bacterial colonization of the wound surfaces with microorganisms that are
typically not considered to be pathogenic (such as enterococci and coagulase-negative
staphylococci) [7]. Senneville et al. attempted to define the true correlation between
cultures of swab samples and cultures of bone biopsy specimens obtained from areas of
osteomyelitis in the diabetic foot. It was found that swab cultures are inaccurate and
unreliable indicators of the pathogenic organism in chronic diabetic foot osteomyelitis and
there was overall poor concordance between the superficial swab culture and bone biopsy
culture results for all microorganisms [8].
Other methods for diagnosing osteomyelitis include radiographic analysis. On plain film,
osteomyelitis is suspected when one or more of the following radiographic signs is observed:
periosteal elevation, cortical disruption, medullary involvement, osteolysis, and sequestra
(segments of necrotic bone separated from living bone by granulation tissue) [9]. Signs of
osteomyelitis only show up on plain film 10-20 days after infection, [10, 11]. Dinh et al,
in their meta-analysis on radiographic modalities, found 54% sensitivity and 68% specificity
in detecting osteomyelitis with plain film versus 90% sensitivity and 79% specificity with
MRI [12].
To the investigators' knowledge, there has been no study that compares all these methods to
determine if there is a superior test to determine osteomyelitis.
;
Observational Model: Cohort, Time Perspective: Retrospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04563325 -
Oral-only Antibiotics for Bone and Joint Infections in Children
|
Phase 4 | |
Not yet recruiting |
NCT06402292 -
Surgical Treatment of Osteoarticular Infections Using Bioactive Bone Substitute
|
N/A | |
Completed |
NCT03846804 -
Next-Generation Sequencing for Pathogen Detection and Quantification in Children With Musculoskeletal Infections
|
N/A | |
Active, not recruiting |
NCT04945434 -
Clinical Effectiveness of S53P4 Bioactive Glass in Treatment of Long-bone Chronic Osteomyelitis
|
N/A | |
Recruiting |
NCT06084754 -
Effect of Pulsed Electromagnetic Field Stimulation on Localized Pediatric Osteomyelitis
|
N/A | |
Recruiting |
NCT05177107 -
Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis
|
Phase 2 | |
Recruiting |
NCT04554108 -
Acute Non-severe Osteomyelitis in Children - Outpatient Management Strategy With Oral Antibiotic Therapy Compared to a Standard Strategy With Conventional Hospitalization and Intravenous Antibiotic Therapy: a Randomized Open-label Non-inferiority Study With Bayesian and Medical-economic Analyses.
|
N/A | |
Recruiting |
NCT02128256 -
CERAMENTâ„¢|G - Bone Healing and Re-infection Prophylaxis
|
Phase 4 | |
Terminated |
NCT03091439 -
Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Patients With Osteomyelitis
|
Phase 2 | |
Recruiting |
NCT04936958 -
RETR(Osteomyelitis)
|
||
Completed |
NCT03802552 -
Cefadroxil and Cephalexin Drug Levels and Dosing in Pediatric Musculoskeletal Infections
|
Phase 1 | |
Completed |
NCT03559530 -
Acinetobacter Baumannii-related Osteomyelitis: Clinical and Epidemiological Characterization
|
||
Completed |
NCT00324922 -
Vancomycin Or Trimethoprim/Sulfamethoxazole for Methicillin-resistant Staphylococcus Aureus Osteomyelitis
|
Phase 3 | |
Completed |
NCT02084147 -
PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases
|
N/A | |
Terminated |
NCT02099240 -
Patients Response to Early Switch To Oral:Osteomyelitis Study
|
Early Phase 1 | |
Withdrawn |
NCT02344511 -
Dalbavancin vs Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis
|
Phase 3 | |
Completed |
NCT00402064 -
The Influence of Bisphosphonates in the Oral Cavity in Children
|
N/A | |
Terminated |
NCT02168816 -
Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis
|
Phase 2 | |
Completed |
NCT02685033 -
Study on the Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Participants With Osteomyelitis
|
Phase 2 | |
Completed |
NCT02335905 -
Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children
|
Phase 1/Phase 2 |